‘EXPANDING FORMULATION IN DOMESTIC AND INTERNATIONAL MARKETS’

“Our new Go-To-Market model is beginning to pay dividends, our new product introductions are performing well, and our big brands continue to outperform the category & the market. At JBCPL, we will continue to build on our strengths, consolidating our position in key therapies as we expand our range of formulations both in the domestic and international markets. We will continue to diversify into complementary therapy areas with our Go-To-Market model ensuring market-beating growth. We foresee headwinds in the international markets receding with a steady revival in our key overseas markets.” - NIKHIL CHOPRA, Chief Executive Officer and Whole Time Director, J.B. Chemicals & Pharmaceuticals, Mumbai